Literature DB >> 1610965

Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties.

G Gong1, A S Whittemore, D West, D H Moore.   

Abstract

During the period 1974 through 1985, employees at Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States) were diagnosed with cutaneous malignant melanoma at approximately three times the rate of the surrounding community. We investigated two explanations for this excess: the first explanation examined was that the recorded incidence of the neighboring community underestimates actual incidence. We estimated the amount of excess attributable to underreporting by using data from a survey conducted among San Francisco Bay Area clinicians and pathologists to determine previously unrecorded occurrences. We found that underreporting has negligible impact on melanoma incidence. The second explanation examined was that heightened medical awareness of the disease among LLNL employees and their physicians has led to greater detection. We found that LLNL melanomas are thinner than those from the surrounding community and that no excess was observed if we limited our attention to thicker, more invasive melanomas.

Entities:  

Mesh:

Year:  1992        PMID: 1610965     DOI: 10.1007/bf00124251

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

1.  Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figures.

Authors:  H K Koh; R W Clapp; J M Barnett; W M Nannery; S R Tahan; A C Geller; J Bhawan; T J Harrist; T Kwan; M Stadecker
Journal:  J Am Acad Dermatol       Date:  1991-04       Impact factor: 11.527

2.  Early diagnosis of cutaneous malignant melanoma at Lawrence Livermore National Laboratory.

Authors:  J S Schneider; D H Moore; R W Sagebiel
Journal:  Arch Dermatol       Date:  1990-06

3.  Malignant melanoma incidence at the Los Alamos National Laboratory.

Authors:  J F Acquavella; G L Tietjen; G S Wilkinson; C R Key; G L Voelz
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

4.  The possible effect of increased surveillance on the incidence of malignant melanoma.

Authors:  R A Hiatt; B Fireman
Journal:  Prev Med       Date:  1986-11       Impact factor: 4.018

5.  Malignant melanoma among employees of Lawrence Livermore National Laboratory.

Authors:  D F Austin; P J Reynolds; M A Snyder; M W Biggs; H A Stubbs
Journal:  Lancet       Date:  1981-10-03       Impact factor: 79.321

6.  A melanoma case-control study at the Los Alamos National Laboratory.

Authors:  J F Acquavella; G S Wilkinson; G L Tietjen; C R Key; J H Stebbings; G L Voelz
Journal:  Health Phys       Date:  1983-09       Impact factor: 1.316

7.  The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State.

Authors:  M R Karagas; D B Thomas; G J Roth; L K Johnson; N S Weiss
Journal:  Am J Epidemiol       Date:  1991-01       Impact factor: 4.897

  7 in total
  1 in total

1.  Melanoma: linked temporal and latitude changes in the United States.

Authors:  J A Lee; J Scotto
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.